Radiotherapy for Head and Neck Cancer with Simultaneous Integrated Boost

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) in patients with head and neck cancers. It aims to assess local and regional control, overall survival, metastasis-free survival, and therapy-related toxicities while documenting patient-reported quality of life. The study follows a prospective, longitudinal design, collecting real-world outcomes and quality measures in accordance with clinical guidelines. Patients with confirmed malignancies will receive individualized treatment plans designed to minimize toxicity while effectively targeting high-risk tumor areas.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 and older with histologically confirmed malignant head and neck tumors, undergoing definitive or adjuvant radio(chemo)therapy at the University Hospital Würzburg

Exclusion Criteria:

* missing informed consent
* mental or physical disorders leading to inability to understand and/or fill the quationary
* judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures

Where it's running

• University Clinic of Wuerzburg
  Würzburg, Bavaria, Germany Recruiting

Study contacts

• Principal investigator: Victor Lewitzki, MD, PhD — University Clinic of Wuerzburg, Department of Radiation Oncology
• Study coordinator: Victor Lewitzki, MD, PhD
• Email: lewitzki_v@ukw.de
• Phone: +49-931-201-28869

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Optical surface guidance for head and neck radiotherapy with open-face mask

  This trial tests whether using optical surface guidance with an open-face mask during radiotherapy for head and neck cancer improves positioning and reduces movement compared with the standard closed mask approach.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07726407

• Health-Oriented Protocol for Epidermal Radiodermatitis

  This study looks at how skin reactions from radiation therapy affect adults with head/neck or pelvic cancers and whether certain factors influence RID outcomes.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, RM · NCT07129525

• Comparing dose painting with standard radiotherapy for head and neck cancer

  This study is testing a new way of giving radiation treatment for head and neck cancer to see if it causes fewer severe mouth sores than the standard method.

  Recruiting at 2 sites Oslo University Hospital · Bergen and 2 other locations · NCT06297902

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

• Airway ultrasound in head and neck cancer patients

  This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.

  Recruiting at 2 sites University Hospital Dubrava · Zagreb, City of Zagreb and 1 other locations · NCT07910149

• Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia

  This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.

  Recruiting at 2 sites Phase 1 Rockefeller University · Minneapolis, Minnesota and 1 other locations · NCT07901959

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.